Roche Diagnostics has announced that the new Elecsys troponin T high-sensitive (hs) assay, for use on cobas and MODULAR Analytics serum work areas, will soon be available to hospital laboratories in the UK and Ireland. This highly sensitive diagnostic assay, which has been developed to improve the detection of myocardial injury and to help identify risk of acute coronary syndromes, detects troponin T in the range 0.003–10 ng/mL serum/plasma.
The new Elecsys troponin T hs assay meets the precision recommendations in the ESC/ACC guidelines. The improved sensitivity of the assay is of great diagnostic and prognostic value, not only in patients with acute coronary syndromes but also in stable patients with a variety of cardiac disorders.
The sensitivity and precision of the new assay will enable more patients with ischaemic symptoms to be identified at an earlier stage, permitting earlier and more targeted treatment.
www.roche-diagnostics.co.uk